Biological and clinical implications of <i>BIRC3</i> mutations in chronic lymphocytic leukemiaFary Diop, Gianluca Gaïdano, Denise Peroni et al.|Haematologica|2019Cited by 87
Precision Medicine Management of Chronic Lymphocytic LeukemiaRiccardo Moia, Gianluca Gaïdano, Andrea Patriarca et al.|Cancers|2020Cited by 38
Targeting p53 in chronic lymphocytic leukemiaRiccardo Moia, Gianluca Gaïdano, Paola Boggione et al.|Expert Opinion on Therapeutic Targets|2020Cited by 26
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphomaRiccardo Moia, Gianluca Gaïdano, Chiara Favini et al.|British Journal of Haematology|2021Cited by 10
XPO1 Mutations May Identify Binet Α Chronic Lymphocytic Leukemia Patients with Shorter Time to First TreatmentRiccardo Moia, Gianluca Gaïdano, Chiara Favini et al.|Blood|2019Cited by 3